ProPhase Labs Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About ProPhase Labs Inc.
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy ProPhase Labs Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ProPhase Labs Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ProPhase Labs Inc. is PRPH:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ProPhase Labs Inc. has its primary listing on NASDAQ. You can trade ProPhase Labs Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ProPhase Labs Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include ProPhase Labs Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like ProPhase Labs Inc..